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Background: Low-intensity transcranial focused ultrasound stimulation (TFUS) holds great promise as a
highly focal technique for transcranial stimulation even for deep brain areas. Yet, knowledge about the
safety of this novel technique is still limited.
Objective: To systematically review safety related aspects of TFUS. The review covers the mechanisms-of-
action by which TFUS may cause adverse effects and the available data on the possible occurrence of such
effects in animal and human studies.
Methods: Initial screening used key term searches in PubMed and bioRxiv, and a review of the literature
lists of relevant papers. We included only studies where safety assessment was performed, and this
results in 33 studies, both in humans and animals.
Results: Adverse effects of TFUS were very rare. At high stimulation intensity and/or rate, TFUS may cause
haemorrhage, cell death or damage, and unintentional blood-brain barrier (BBB) opening. TFUS may also
unintentionally affect long-term neural activity and behaviour. A variety of methods was used mainly in
rodents to evaluate these adverse effects, including tissue staining, magnetic resonance imaging, tem-
perature measurements and monitoring of neural activity and behaviour. In 30 studies, adverse effects
were absent, even though at least one Food and Drug Administration (FDA) safety index was frequently
exceeded. Two studies reported microhaemorrhages after long or relatively intense stimulation above
safety limits. Another study reported BBB opening and neuronal damage in a control condition, which
intentionally and substantially exceeded the safety limits.
Conclusion: Most studies point towards a favourable safety proﬁle of TFUS. Further investigations are
warranted to establish a solid safety framework for the therapeutic window of TFUS to reliably avoid
adverse effects while ensuring neural effectiveness. The comparability across studies should be improved
by a more standardized reporting of TFUS parameters.
© 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Weak Transcranial Focused Ultrasound Stimulation (TFUS) aims
to modulate neural activity by delivering a focused ultrasonic beamMagnetic Resonance, Centre
Copenhagen University Hos-
Hvidovre, Denmark.
Inc. This is an open access article uto a small target area in the brain. Currently, interest in TFUS is
strongly increasing as it holds the promise of a far better spatial
resolution than established non-invasive stimulation techniques
and of the ability to reach deep brain areas [1]. This might open up
intriguing new applications such as epilepsy treatment or pre-
surgical diagnostics prior to electrode implantation for deep-
brain stimulation [2,3]. TFUS is also attractive because it can be
readily combined with neuroimaging modalities such as functional
magnetic resonance imaging (fMRI) and electroencephalographynder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C. Pasquinelli et al. / Brain Stimulation 12 (2019) 1367e13801368(EEG) without interfering with the recordings, as it applies acoustic
waves rather than electric or magnetic ﬁelds.
Firmly establishing its safety proﬁle is a central requirement
when aiming to move TFUS from initial pilot studies towards
broader testing in humans in-vivo. Reviews on safety and bio-
effects of ultrasound (US) in diagnostics [4] and therapy [5] as
well as guidelines for the clearance of commercial diagnostic and
therapeutic US systems as medical devices [6] are available and
constitute a benchmark to avoid harmful effects also for TFUS.
Relating the TFUS parameters to these guidelines, as done in many
of the published studies, might be considered a conservative
choice. However, several aspects put TFUS in a special position.
TFUS usually employs lower frequency compared to diagnostic ul-
trasound (usually upper kHz range vs. MHz) and longer pulse
bursts. TFUS has a static focus so that the total energy delivered at
the focal point can be higher than the maximal local energy deposit
for diagnostic US, as the latter uses scanning approaches. The
mechanism-of-action of TFUS is still poorly understood, rendering
it more difﬁcult to principally exclude harmful effects. In addition,
current ﬁndings about the dose-response curve of TFUS [7] suggest
that future therapeutic applications might aim to use intensities
above the safety limits for diagnostic US in order to increase the
robustness of the neural effects. Such a choice requires solid
knowledge about the safety margin of TFUS. Along similar lines,
accurate dose control for human TFUS is complicated by the pres-
ence of the skull, which strongly attenuates the beam. The atten-
uation depends on the individual skull thickness and composition
[8], which are difﬁcult to account for and lead to conservative in-
tensity choices with an increased risk of underdosing. If the safety
margin of TFUS is not well established, the use of more lenient
dosing strategies to mitigate this problem is not feasible.
There is a pressing need to establish speciﬁc safety guidelines
for TFUS. Yet, the current knowledge about the risk-beneﬁt ratio
and the therapeutic window of TFUS is still rudimentary because
TFUS is at an early stage of development. Indeed, no dedicated
phase I safety human study has been performed so far, but the
safety proﬁle needs to be systematically investigated and moni-
tored to ensure the patients’ safety. However, relevant information
is already available today, because some of the published studies on
TFUS in animals or humans included safety-relevant tests. Here, we
systematically summarize these ﬁndings to give an overview of the
current state of knowledge about TFUS safety. We start by
describing the relevant physical parameters used to characterize
the TFUS stimulus. We then shortly describe the known physical
mechanisms by which ultrasound can cause tissue damage and we
introduce the established safety indices, based on the beam pa-
rameters. Finally, we introduce the methods that have so far been
applied to test for adverse effects of TFUS, and list the corre-
sponding results. In the discussion, we summarize the implications
of the available ﬁndings for in-vivo human TFUS applications.
Material and methods
Literature review on the safety of TFUS
For this systematic review, we followed the PRISMA guidelines
[9,10]. Details on the implementation of the PRISMA requirements
in our review are stated in the Supplementary material (Table S1).
Our review was based on searches in PubMed (www.ncbi.nlm.nih.
gov/pubmed) and bioRxiv (https://www.biorxiv.org/) for published
and pre-published studies, using the keywords ‘tFUS’, ‘LIFUP’,
‘noninvasive brain stimulation focused ultrasound’, ‘neuro-
modulation brain transcranial ultrasound’, ‘focused ultrasound
transcranial brain stimulation’ and ‘pulsed ultrasound brain stim-
ulation’. The eligibility criteria were low intensity, low frequencyTFUS in the brain of animals or humans with safety assessment,
without use of microbubbles. Additional sources were reviews of
the literature lists of relevant papers, and papers pointed out by the
reviewers during the peer-review process. Fig. 1 shows details of
the literature search. The last complete search was performed in
January 2019 by one of the authors, and the last update was done in
June 2019. From each paper, the sonication parameters and the
methods used to assess safety and adverse effects were extracted as
shown in Table 2 and Table 3 and categorized as described further
below. Often, only some of the safety indices were reported. In that
case, we give estimated values when possible.
Mechanism of ultrasound neuromodulation
Despite many hypotheses, the exact underlying mechanism of
neuromodulation using low-intensity ultrasound is yet to be un-
derstood [11]. The initial hypotheses for the ultrasound neuro-
modulation were thermal effects and acoustic cavitation. While an
increase in the tissue temperature could perturb neuronal activity
levels, the temperature increase due to low-intensity ultrasound is
often less than 0.1 C. Thus, the thermal effects of low-intensity
ultrasound are most likely negligible. The second hypothesis is
based on acoustic cavitation. This hypothesis postulates that the
ultrasound generates nanobubbles in the lipophilic zone of the
plasma membrane, which then vibrates according to the pressure
variations, alters the local curvature of the bilayer, and changes
overall neuronal excitability [12]. However, since nanobubbles are
formed at an intensity larger than 100mW/cm2, generation of
micro or nanobubbles at the intensity used in standard neuro-
modulation protocols must be conﬁrmed. The recent hypotheses
now focus more on the effects of acoustic radiation forces on the
permeability of the ion channels, such as mechanosensitive chan-
nels [13] and voltage-gated calcium, sodium, and potassium
channels [14]. Another kind of hypotheses includes plasma defor-
mation, which postulates that vibration of surrounding extra- and
intracellular environment evokes mechanical changes in either the
plasma membrane tension or the lipid bilayer and modulates
neuronal activities [14].
Contrary to these works on the mechanisms involved with
direct modulation of ion channels and membranes, an indirect
in vivo ultrasound neuromodulation through auditory or cochlear
pathways has been also recently proposed [15,16]. These studies
demonstrated that ultrasound-induced activities were eliminated
or reduced upon transection of the auditory nerves or removal of
cochlear ﬂuids. These results raised an important question of
whether direct activation of neurons in the intact brain is possible.
While more in-depth studies on the experimental protocols such as
sharpness of the pulse, pulse repetition frequency, and bone
transduction must be performed, these studies underscore the
need for a solid understanding of the underlying mechanism of
ultrasound neuromodulation [16].
Physical parameters and safety indices of US waves
A sketch of an experimental setup for TFUS is shown in Fig. 2A,
using the stimulation of a rat as example. The main indices used to
assess safety are:
 Ispta (spatial peak temporal average intensity) is the temporal
average intensity, calculated at the position of the spatial
maximum
 Isppa (spatial peak pulse average intensity) is the pulse average
intensity, calculated at the position of the spatial maximum
 MI (mechanical index) gives an estimation of the likelihood of
inertial cavitation
Fig. 1. Selection process for the studies included in this review. The scheme is from Refs. [9,10].
C. Pasquinelli et al. / Brain Stimulation 12 (2019) 1367e1380 1369 TI (thermal index) is the steady-state temperature increase in
soft tissue during ultrasound sonication
 TIC (thermal index for cranial bone) is a modiﬁcation of TI, when
the skull is close to the transducer face
Ispta, TI and TIC are related to the risk of thermal bio-effects,
while Isppa and MI are related to the risk of cavitation. The upper
limits for these ﬁve indices allowed for diagnostic ultrasound are
shown in Table 1. It should be noted that another guideline, IEC
standard 60601-2-5 for physiotherapy US equipment, sets an upper
limit for the “effective intensity’’, deﬁned as the ratio of acoustic
output power to effective radiating area, of 3W/cm2. The standard
also states that this value should only be reached for short times to
prevent substantial heating. The “effective intensity’’ of 3W/cm2 is
usually interpreted as the upper limit for Ispta [17e19]. Lee and
colleagues [17] compare the intensities used in their study against
this limit rather than using the FDA guidelines for diagnostic US.
Complementary to TI, the temperature increase at the target can beTable 1
Allowed limits for MI, TI, Ispta and Isppa according to the FDA guidelines for diagnostic
ultrasound. The limit for TI also applies to TIC when bone is close by.
Ispta (mW/cm2) Isppa (W/cm2) MI TI
720 190 1.9 6calculated as DTmax (equation 7 and 8 in Supplementary material)
or through the bio-heat equation [20e22]. A more detailed expla-
nation of these indices and formulae can be found in the Supple-
mentary Material.Mechanisms underlying tissue damage by US
Ultrasound waves may cause harmful effects on tissues via two
physical mechanisms, mechanical and thermal. The main me-
chanical effect is cavitation, in which vapor cavities (or “bubbles”)
form in the soft tissues during the periods of low pressure (i.e. the
minima) of the acoustic wave cycles. Depending on intensity and
center frequency, this can result in a stable oscillation (stable or
non-inertial cavitation) or can result in violent bubble collapses
(inertial cavitation) that create large forces in their neighborhood.
The air bubbles can have an endogenous origin (for example in the
lungs or intestine), or they can be created by the mechanical wave
itself, if the peak rarefaction pressure (i.e. the pressure during the
minima) is small enough to allow the liquid to reach vaporization.
Alternatively, ultrasound contrast agents (UCA), which contain
microbubbles, can be injected for, e.g. clinical purposes [23] or gene
and drug delivery [24].
When a mechanical wave propagates linearly in a medium, its
amplitude decreases exponentially starting from the source. The
attenuation is caused by both scattering, i.e. the change in the
Table 2
Overview of the parameters used in the reviewed studies. Ispta values very often exceeded the limits for diagnostic US. Cases where the Ispta values were higher than 3W/cm2, corresponding to the limit for physiotherapeutic US,
are highlighted in bold. Also one case in which MI exceeded the limit of 1.9 is marked in bold. If needed, we calculated missing parameters from the available data stated in the paper, which we indicate by “*” in the table. When
the peak pressure was reported, MI was calculated using its deﬁnition (eq. (2)), and Isppa in water as indicated in Fig. 1 (r¼ 1000 kg/m3, c¼ 1500m/s). Ispta was ﬁnally determined as Isppa x DC. 1) For [27], only the parameters
employed in the safety tests of that study are listed here. 2) For [28], only the parameters for the main experiment are reported. 3) In Ref. [66], Ispta was determined by using ISI instead of PRP as the total pulse duration; this
strongly reduces the value. 4) For [47], MI, Isppa and Ispta are not stated, but authors asserted that they used the same waveform as [62]. 5) Not clear if it is in water or after cranial transmission. 6) A spatial average of intensity of
25e30W/cm2 is used. 6) Modulated focused ultrasound means that two transducer, one driven at 2.25MHz and the other at 1.75MHz, producing a difference frequency at 500 kHz at the focus, and a carrier frequency of 2MHz.
Study Target Parameters Observed neural effect and adverse effect (if
any)
fc [kHz] TBD PRF SD Number of
sonica-tions
ISI MI Isppa Ispta
Legon et al.
preprint
[55]
Human
thalamus or M1
Follow-up questionnaire of 7 experiments, only 3 are published so far ([62,65] and one preprint [47]) This work presents results on safety
assessment.
Verhagen
et al. [22]
Non-human
primate SMA,
FPC and pre-
SMA
250 30ms 10 Hz 40 s 1 e 2.4 in water *
1.68 after cranial
transmission
(estimated from
pressure peak) *
48W/cm2 in water *
23.52W/cm2 after cranial tx *
14.4W/cm2 in
water *
7.056W/cm2 after
cranial tx *
Reversible change in brain connectivity, that
last up to 2 h after treatment.
Fisher et al.,
2018
[31]
Mice primary
somatosensory
cortex
510 500 ms 1 kHz 1 s 1 e 0.24 in water * 0.69W/cm2 in water 345mW/cm2 in
water *
Early sensory-evoked cortical responses
(3.0± 0.7ms earlier) and alteration of Ca2þ
responses.
510 continuous ? ? ? ? 280W/cm2 in water e Parameter tested as control.
BBB intentionally opened. An increased
number of astrocytes was found.
Tufail et al.,
2010
[27] 1)
Mouse motor
cortex
500 0.45ms 1.5 kHz 67* (53)
ms
180* 10 s 0.13 after cranial
tx
211.72mW/cm2 after cranial tx
*
142.2mW/cm2
after cranial tx
Neuron's spike frequency and c-fosþ cell
density increase and the activity of
endogenous brain-derived neurotrophic
factor (BDNF) were stimulated.
Low frequency (250 KHz) and low intensities
(up to around Ispta¼ 80mW/cm2) result in
more robust EMG response.
The EMG failure probability increased with
shorter ISI (200ms), but decrease with
multiple stimuli.
BBB intentionally opened with the use of
microbubbles.
Kim et al.,
2012
[28] 2)
Rat abduncens
nerve
350 0.36ms 1.5 kHz 200ms 10 1 s 0.9 after cranial tx
(estimated)
8.6W/cm2 after cranial tx
(estimated)
4.6W/cm2 after
cranial tx
(estimated)
fc¼ 650 kHz and Isppa in the range 0.5e20W/
cm2 did not elicit eye movement in any
animals. Movements observed when
fc¼ 350 KHz for an Isppa of 8.6W/cm2.
Lee et al.,
2015
[34]
Sheep SM1 and
V1
250 1ms 500 Hz 300ms 100 (groups
of
sonications
repeated up
to 8 times
per animal)
5 s
(motor
cortex)
or 1 s
(visual
cortex)
in the range 0.5
e1.4 after cranial
tx
Up to 11.8W/cm2 after cranial
tx eSM1
Up to 14.3W/cm2 after cranial
tx -V1
Up to 5.9W/cm2 *
after cranial tx
eSM1
Up to 7.15W/cm2 *
after cranial tx -V1
MEP or VEPs were detected over a certain
intensity threshold, which varied across
sheep and was always above diagnostic
limits, and in some cases also above the
physiotherapy limit. In both cases, higher Isppa
result in stronger response amplitude.
Four animals which underwent 600
sonications at Isppa¼ 6.6e10.5W/cm2
showed micro-hemorrhages in the primary
visual cortex.
Yoo et al.,
2011
[29]
Rabbit (after
craniotomy),
SM and visual
area
(the bottom line
is only for
temperature
increase study)
690 0.05, 0.5,
10 and
50ms
10, 20, 100
and
1000 Hz
0.5, 1,
1.5, 2, 9 s
1 e <0.5 in water (for
an Isppa¼ 3.3W/
cm2, resulting in
clear BOLD
activity)
3.3, 6.4, 9,5, 12.6W/cm2 in
water
1.6W/cm2 in water
(for Isppa¼ 3.3W/
cm2)
The BOLD activation was observed at a much
lower acoustic intensity (Isppa¼ 3.3W/cm2,
Ispta¼ 1.6W/cm2) compared to the intensity
that resulted in forepaw movement
(Isppa¼ 12.6W/cm2, Ispta¼ 6.3W/cm2)
690 0.5ms 100 Hz 27 s 1 e ? 23W/cm2 1.15W/cm2 Parameter tested as control for temperature
increase
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Lee et al.,
2015
[51]
Human S1 250 1ms 500 Hz* 300ms Around 200 3 s 0.62 after cranial
tx (maximal
simulated value
across N¼ 12
subjects)
3W/cm2 in water
2.5W/cm2 after cranial tx
(maximal simulated value)
1.5W/cm2 in water
1.25W/cm2 * after
cranial tx
(maximal
simulated value)
Tactile sensations were not the same among
subjects, but mostly at the hand area
contralateral to the sonicated hemisphere. 1
out of 12 subjects did not report any
sensation. Different peak amplitudes of EEG
recording of SEP with and without
stimulation.
Lee et al.,
2016
[54]
Human S1þS2 210 1ms 500 Hz 500ms 20 7 s ? 35W/cm2 in water
<8.8W/cm2 after cranial tx
(estimated)
17.5W/cm2 in
water
< 4.4W/cm2 after
cranial tx
(estimated)
Response rates of elicited sensations during
the FUS procedures were different among
subjects (68 ± 28% S1, 59 ± 22% S2, 61 ± 26%
S1þS2, average ± sd across subjects).
Kim et al.,
2014
[35]
Rats
somatomotor
area
350 and 650 0.25, 0.5,
1, 2, 3 or
5ms
in the
range
[0.06, 2.8]
kHz
and
continous
wave
150,
200, 300
or
400ms
? 2 or 3 s 1.38
(value for animal
with signs of
bleeding)
22.4W/cm2 after cranial tx
(max value reported,
corresponding to animal with
signs of bleeding)
11.2W/cm2 after
cranial tx
(max value
reported)
Motor responses were observed at minimum
threshold (Isppa¼ 4.9e5.6W/cm2, Ispta¼ 2.5
e2.8W/cm2) in a limited range of sonication
parameters (TBS¼ 1e5ms, 50% of duty cycle,
and SD¼ 300ms, at fc¼ 350 kHz). Pulsed
sonication elicited motor responses at lower
acoustic intensities than its equivalent
continuous sonication (Isppa¼ 7.73W/cm2).
One animal which underwent a sonication of
Ispta¼ 11.2W/cm2 for a short period of time
(<9 s using 1ms TBD, 50% duty cycle and
300ms SD) showed signs of local bleeding.
Kim et al.,
2013
[32]
Rats 350 0.5ms 1 kHz 300ms 1200 * 2 s 0.74 after cranial
tx
6W/cm2 * after cranial tx 3W/cm2 after
cranial tx
Changes in glucose metabolism for up to
more than 1 h after sonication.
Lee et al.,
2016
[17]
Human V1 270 1ms 500 Hz 300ms 50 13 s
(fMRI)
or 2.5 s
(EEG)
2.8 * in water
1.2 after cranial tx
(maximal
simulated value
across N¼ 19
subjects)
16.6W/cm2 in water
11.6W/cm2 after cranial tx
(maximal simulated value)
8.3W/cm2 in water
*
5.8W/cm2 * after
cranial tx (maximal
simulated value)
fMRI: 11 out of 19 participants reported the
perception of phosphenes, and a clear fMRI
response.
EEG: 10/10 subjects reported phosphene
sensation. Changes in VEP EEG peak.
Yoo et al.,
2011
[56]
Rats thalamus 650 0.5ms 100 Hz 20min 1 e 0.61 after cranial
tx
6W/cm2 after cranial tx 300mW/cm2 after
cranial tx
The sonication reduced the time to
emergence of voluntary movement from
intraperitoneal ketamine-xylazine
anesthesia. A preliminary test showed that a
Isppa¼ 3.3W/cm2 failed to decrease the
duration of the anesthetic state.
Defﬁeux
et al.,
2013
[66]
Monkey frontal
eye ﬁeld
320 1ms 1 kHz 100ms 40 30 s 1.06 in water *
0.6 after cranial tx
(average across
several skull
positions)
12W/cm2 in water*
4W/cm2 after cranial tx
6W/cm2 in water*
13.5mW/cm2 after
cranial tx 3)
2W/cm2 after
cranial tx (using
standard formula) *
Ultrasound increased antisaccade latencies in
two monkeys.
Mueller
et al.,
2014
[67]
Human
somatosensory
cortex
500 0.36ms 1 kHz 500ms 120 6 s 1.13 in water 23.9W/cm2 in water 8.6W/cm2 in
water*
The phase distribution of beta frequencies
was altered, together with a change in phase
rate of beta and gamma frequencies.
Legon et al.,
2014
[62]
Human S1 500 0.36ms 1 kHz 500ms ? ? 1.13 in water 23.9W/cm2 in water 8.6W/cm2 in
water*
Amplitudes of SEPs (recorded by EEG) elicited
by median nerve stimulation were
signiﬁcantly attenuated. The spectral content
of sensory-evoked brain oscillations were
signiﬁcantly modulated by tFUS.
Legon et al.
preprint
[47]
Human M1 500 0.36ms 1 kHz 500ms 1 e 4) 4) 4) The amplitude of single-pulse TMS MEPs was
decreased; the intracortical facilitation was
attenuated; no effect on intracortical
inhibition. Ultrasound reduces reaction time
on a simple stimulus response task
(continued on next page)
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Table 2 (continued )
Study Target Parameters Observed neural effect and adverse effect (if
any)
fc [kHz] TBD PRF SD Number of
sonica-tions
ISI MI Isppa Ispta
Lee et al.,
2018
[30]
Rats
(anesthetized
and awake)
motor cortex
600 1ms 500 Hz 300ms 10 5e10 s 1.38 Minimum value: 2.1W/cm2;
incremented by 1W/cm2;
maximum value: 14.9W/cm2
5)
7.5W/cm2
5)
Different thresholds to evoke observed motor
response: Isppa¼ 3.4± 1.8W/cm2 for the
awake condition (grand mean response rate
76.2%)
Isppa¼ 10.2± 2.4W/cm2 (grand mean
response rate 68.6%) or 12.4± 2.8W/cm2
(grand mean response rate 38.6%) for 2
different types of anesthetics5)
Yoo et al.,
2017
[48]
Rats
somatosensory
cortex
650 0.5ms 100 Hz 10min 1 e ? 4.2W/cm2
5)
210mW/cm2
5)
Different SEP features compared to controls
were evident and persisted beyond 35min
after the administration of FUS.
Yang et al.,
2018
[52]
Monkey S1 250 0.252ms 2 kHz 300ms 10 * 3 s 1.87 in water
1.08 after cranial
tx (estimated after
measurement on
skull attenuation)
29.5W/cm2 in water
9.9W/cm2 after cranial tx
1.34W/cm2 in
water
0.452W/cm2 after
cranial tx
Excitation effects with BOLD fMRI not only at
the target but also off-target somatosensory
and associated brain regions as a cause of
modulation
in downstream brain regions.
Daniels
et al.,
2018
[39]
Pigs (after
craniotomy)
auditory and
rats inferior
colliculus
230 (1000
element
transducer)
100ms 0.333 Hz * 52 s 1 e Rats: 0.08 *
Pigs and rats: 0.17
*
5)
Rats: 2.3W/cm2
Pigs and rats: 4.6W/cm2
5)
Rats: 765.9mW/
cm2 *
Pigs and rats:
1.53W/cm2 *
5)
AEP decreases by 59.8± 3.3% (with
Isppa¼ 2.3W/cm2) and by 36.9± 7.5% (with
Isppa¼ 4.6W/cm2) of the baseline value in
rats.
AEP amplitudes decreased to an average of
27.7± 5.9% of baseline in pigs.
This effect lasted between 30min and 1
month in most treated animals.
Kim et al.,
2018
[33]
Mice motor
cortex
183 (CMUT 32
elements
array)
4.5ms 200 Hz 200ms 25 Around
9.6 s
0.12 *
before cranial tx
Up to 61.5mW/cm2 before
cranial tx
Up to 55.4mW/cm2
before cranial tx
At an intensity of Ispta¼ 34.1mW/cm2, the
average stimulation success rate of four mice
was over 70%.
Dallapiazza
et al.,
2018
[21]
Swine thalamic
regions
1.145MHz
(single
element)
650 and
220 kHz (multi
element
phased array
transducer)
43.7ms 10 Hz 40 s 1 e 0.53
5)
?
6)
? Suppression of SSEP amplitude
Kim et al.,
2015
[49]
Rats visual
cortex
350 0.5ms 20, 100,
166 Hz
150 s 1 e Max 0.75
5)
1, 3, 5W/cm2
5)
Max 250mW/cm2
5)
Isppa¼ 1W/cm2, TBD¼ 0.5 at PRF¼ 100 Hz
and Isppa¼ 3W/cm2, TBD¼ 0.5ms,
PRF¼ 20 Hz, corresponding to 50 and 30mW/
cm2 Ispta did not change VEP.
Isppa¼ 3W/cm2 with TBD¼ 0.5ms and
PRF¼ 100 Hz (5% duty cycle) successfully
suppressed the VEP.
Higher duty cycle (8.3%) increased the VEP.
The same effect was observed at Isppa¼ 5W/
cm2 and 5% duty cycle.
Min et al.,
2011 [2]
Rats thalamus 690 0.5ms 100 Hz 180 s 1 e 0.33 after cranial
transmission
2.6W/cm2
after cranial transmission
130mW/cm2
after cranial
transmission
Suppression of the number of epileptic signal
bursts. Average among all 9 rats that
underwent treatment.
Baek et al.,
2018
[19]
Mice lateral
cerebellar
nucleus (LCN)
350 0.5ms 1 kHz 300ms 600 2 s 0.54 in water 2.5W/cm2 in water 1.25W/cm2 in
water
Enhancement of sensorimotor recovery after
stroke.
Decreased level of brain edema and tissue
swelling in the affected hemisphere 3 days
after the stroke.
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Folloni et al.
[46]
Monkey
amygdala and
anterior
cingulate cortex
(ACC)
250 30ms 10 Hz 40 s 1 e Maximum 2.64 in
amygdala and
1.64 in ACC *
(from estimation
after cranial
transmission)
Maximum 51W/cm2 in
amygdala and 17W/cm2 in ACC
(estimation after cranial
transmission)
Maximum 15.3W/
cm2 in amygdala
and 5.3W/cm2 in
ACC (estimation
after cranial
transmission)
After TFUS, the functional coupling of the
stimulated areas, but not of control areas, was
selectively reduced. This effect was measured
by fMRI and lasted for more than 1 h after
stimulation.
Li et al.,
2016
[36]
Mice motor
cortex
1MHz (and
high frequency,
5MHz)
0.5ms 1 kHz 300ms 20 *
600 * (for
safety
assessment)
3 s ? 260e460mW/cm2 after cranial
transmission *
From 130 to
230mW/cm2 after
cranial
transmission
The peak EEG amplitude increased with
increasing Ispta.
Yang et al.,
2012
[37]
Rats thalamus 650 0.5ms 100 Hz 20min 1 e 0.2 3.5W/cm2 after cranial
transmission
175mW/cm2 after
cranial
transmission
Extracellular GABA level started to decrease
upon sonication and remained reduced
compared to control group up to 100min
after the end of sonication. The same effect
was not observed for the extracellular
glutamate level.
Han et al.,
2017
[38]
Mice motor
cortex
350 0.23ms 1.5 kHz 66.67ms 600 * (for
safety
assessment)
2 s 0.1e1.16 * 3.38e39.5W/cm2 *
10W/cm2 * (for safety
assessment)
-all after cranial transmission-
1.16e13.55W/cm2
3.46W/cm2 (for
safety assessment)
-all after cranial
transmission-
The robustness of the visual observed
responses increased and the latency of the
response decreased with increasing Ispta.
Ispta¼ 3.46 w/cm2 was sufﬁcient to induce
strong motor response; no response was
observed for Ispta<1.16W/cm2. Ultrasound-
induced motor responses were inhibited
more than 20min after ketamine injection.
This was conﬁrmed in in vitro cortical neuron
sample by ﬂuorescence calcium imaging,
showing a dose-dependent effect.
Gulick et al.,
2017
[45]
Rat motor
cortex (after
craniotomy)
200 0.5ms 1 kHz 300ms
or 3ms
? 2 s or
10 s
Max 3.1 9W/cm2 * or
30W/cm2 *
4.5W/cm2 or
9mW/cm2
US directly evokes hindlimb movement, even
at short burst (3ms) and had short latency
(10ms) and long refractory (3 s) periods. US
modulation signiﬁcantly suppressed forelimb
and hindlimb responses following ECS for
several minutes after the stimulation, but
shows no short-term effect.
Younan
et al.,
2012
[50]
Rat cortex
(target to elicit
motor response,
not
corresponding
to motor
cortex)
320 0.23ms 2 kHz 250ms ? 10 s From 0.7 to 1.77 * Isppa of 7.5W/cm2 (to have 50%
response) in water. Via
computer stimulation, it
corresponds to 17.5W/cm2
after cranial transmission due
to reverberation
3.75W/cm2 in
water and 8.75W/
cm2 after cranial
transmission * (to
have 50% response)
A pressure threshold of 0.79 and 0.59MPa
was required to reach 50% of responsiveness,
for deep or light anesthesia stage,
respectively, and the sigmoid respond was
less sharp in the light anesthesia stage. These
pressures corresponded to an average Isppa of
7.5W/cm2.
Mehic et al.,
2014
[40]
Different
locations in
mice cortex
500 (from
unfocused
ultrasound or
modulated
focused
ultrasound 6),
mFUS)
0.2ms 1.5 kHz 10 s 1 e ? 0.45e16W/cm2 for unfocused
US *
3e33W/cm2 for mFUS *
0.15e5.25W/cm2
for unfocused US
1e10W/cm2 for
mFUS
Increasing the Ispta increase the motor
movement robustness, assessed by visual
assessment with unfocused US and mFUS,
and the normalized success rate in mFUS.
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Table 3
Overview of the safety assessments included in the reviewed studies. The involvedmethods are: ﬂuorescein isothiocyanate-dextran (FITCeDextran), trypan blue dye (T.b.), Evans blue dye (E.B.), magnetic resonance contrast agent
(MR c.a.) to assess the BBB opening; antibodies to Caspase-3, quantitative transmission electron microscopy (e.m.), hematoxylin and eosin (H&E), terminal deoxynucleotidyl transferase dUTP Nick-End Labeling (TUNEL) assay,
cresyl violet (c.v.), GFAP (glial ﬁbrillary acidic protein), VAF (Vanadium acid fuchsin) and luxol fast blue dye (LFB) to monitor cell death, damage, brain ultrastructure and hemorrhage; Sensors (thermo-couple [27,28,33,45,48] or
optical ﬁber based thermal sensor [36]), maximum temperature increase, (equation (7) to estimate DTmax), magnetic resonance thermometry (MR th.) and the bioheat equation for the temperature increase; motor task (m.t.) or
other for behavioral assessments. 1) safety assessed in rats that did not undergo pentylenetetrazol (PTZ) injection to induce epileptic activity [2] or photothrombosis procedure to induce ischemic stroke [19].
Target BBB integrity Cell death, damage, brain ultrastructure and
hemorrhage
Thermal effect Behaviour
FITC
eDextran
T.b. E.B. MR
c.a.
Caspase-
3
E.m. H&E TUNEL C.v. GFAP VAF MRI LFB Sensors DTmax MR
th.
Bioheat
eq.
M.t. Other
Legon et al. preprint
[55]
Human thalamus or M1 X
Verhagen et al. [22] Non-human primate SMA, FPC and pre-SMA X X X
Fisher et al., 2018 [31] Mice primary somatosensory cortex X X
Tufail et al., 2010 [27] Mouse motor cortex X X X X X X
Kim et al., 2012 [28] Rat abduncens nerve X X X X
Lee et al., 2015 [34] Sheep SM1 and V1 X X X
Yoo et al., 2011 [29] Rabbit (after craniotomy), SM and visual area X X X X X X
Lee et al., 2015 [51] Human S1 X X
Lee et al., 2016 [54] Human S1þS2 X
Kim et al., 2014 [35] Rats somatomotor area X X
Kim et al., 2013 [32] Rats X X
Lee et al., 2016 [17] Human V1 X X
Lee et al., 2018 [30] Rats (anesthetized and awake) motor cortex X X X X X X X
Yoo et al., 2017 [48] Rats somatosensory cortex X X
Yang et al., 2018 [52] Monkey S1 X
Daniels et al., 2018
[39]
Pigs (after craniotomy) auditory and rats inferior colliculus X X X X
Kim et al., 2018 [33] Mice X X X
Dallapiazza et al. [21] Swine thalamic regions X X X X
Min et al., 2011 [2] Rats thalamus 1) X X
Baek et al., 2018 [19] Mice lateral cerebellar nucleus (LCN) X 1) X X
Li et al., 2016 [36] Mice motor cortex X X
Yang et al., 2012 [37] Rats thalamus X
Han et al., 2017 [38] Mice motor cortex X
Gulick et al., 2017 [45] Rat motor cortex (after craniotomy) X X
Younan et al., 2012
[50]
Rat cortex (target to elicit motor response, not corresponding tomotor
cortex)
X
Mehic et al., 2014 [40] Different locations in mice cortex X
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Fig. 2. Overview of the TFUS setup and parameters. A) The ultrasound pressure wave is generated by a transducer and delivered to the target through a guide ﬁlled with acoustic
gel. B) The pressure stimulus over time is shown to indicate the main parameters. C) The main intensity values are shown for a ﬁxed space position, together with their relationship
with the pressure signal.
C. Pasquinelli et al. / Brain Stimulation 12 (2019) 1367e1380 1375direction of wave propagation due to the presence of microscopic
obstacles along the beam, and absorption. Absorption is the process
by which the wave energy is converted into heat, and therefore the
medium is heated. Several ways to model or monitor the resulting
temperature increase in the medium exist, and they will be further
discussed below.
Types of adverse and side effects caused by TFUS
In this section, we summarize the potential adverse and side
effects, which have so far been tested in TFUS studies, and brieﬂy
outline the employed techniques to assess the occurrence of these
effects. The majority of results were obtained in animal studies,
which tested for the following effects:
 Blood-brain barrier (BBB) opening: The BBB is a semi-permeable
membrane formed by endothelial cells which separates thevessels and the central nervous system (CNS) [25]. Air bubbles
subjected to cavitation can break the BBB. Exploiting this effect,
TFUS combinedwith US contrast agents is tested as amethod for
targeted drug delivery [26]. However, BBB opening is undesired
for normal TFUS. Assessing BBB integrity is usually based on the
intravenous injection of a substance, which cannot cross the
barrier under normal conditions, prior to sonication. It is then
tested whether TFUS causes the substance to diffuse into brain
tissue. The dyes ﬂuorescein isothiocyanate-dextran (FITC-
dextran) [27], trypan blue [28e30] or Evans blue [31] have been
used for this purpose, and their presence inside the brain was
investigated in post-mortemmicroscopy analyses of brain slices.
Alternatively, an MRI contrast agent (a gadolinium chelate) was
injected before the stimulation and its penetration into brain
tissue was tested by assessing the MRI signal change due to the
contrast agent [29].
C. Pasquinelli et al. / Brain Stimulation 12 (2019) 1367e13801376 Bleeding: The occurrence of bleeding has been investigated us-
ing tissue staining, in particular hematoxylin and eosin (H&E)
staining [2,19,22,28,32e38], which reliably stain blood cells. Yet,
H&E staining is not speciﬁc to blood cells and thus requires
experience to correctly interpret the results.
 Cell death and damage: A general approach to qualitatively
analyze the presence of cell death and damage is through H&E
staining [2,19,21,22,28e30,32e40], as described above, cresyl
violet Nissl staining [22], or luxol fast blue dye (LFB) [21], used to
identify myelin in nervous tissue. Cell death can be of two types,
apoptosis and necrosis. While apoptosis is part of the normal life
cycle of the cells, necrosis is harmful and triggered by external
factors or disease. It is possible to differentiate between both
types of cell death based on morphological criteria, but this
requires experience [41]. Additional techniques speciﬁcally label
apoptotic cells and have therefore been used to distinguish be-
tween apoptosis and necrosis. For example, the presence of
fragmented DNA is a sign of apoptosis, and not necrosis, and it
can be labeled by terminal deoxynucleotidyl transferase (TdT)
dUTP Nick-End Labeling (TUNEL) assay [2,29]. Alternatively,
since apoptosis is mediated by caspase [42], standard immu-
nocytochemistry techniques with antibodies against cleaved
caspase-3 can be used [27,30].
An alternative approach to detect cell damage is staining for
acidophilic cells, for example with VAF (vanadium acid fuchsin)
[30,43]. Acidophilia refers to the property of cells of staining
readily with an acid dye and occurs after acute neuronal damage
and death in brain ischemia.
Finally, also transmission electron microscopy has been used
to quantitatively observe the effect of ultrasound on brain ul-
trastructure (postsynaptic density, docked vesicles, etc.) [27]. It
has been shown that neural trauma causes an abnormal increase
in the number of astrocytes [44] that can be detected by the
expression of GFAP (glial ﬁbrillary acidic protein) [30,31,39]. One
study assessed possible permanent tissue damage after soni-
cation in rats using MRI [39].
 Irreversible changes of neural activity: Recordings after the son-
ication can determine whether changes in neural activity are
reversible and characterize the duration of recovery. The effects
on local neural activity in the TFUS target region can be detected
directly via invasive recordings or voltage sensitive dyes [31] or
Ca2þ imaging in transgenic mice that express the green ﬂuo-
rescent calcium indicator [31]. TFUS-related changes in extra-
cellular concentrations of excitatory and inhibitory
neurotransmitters such as glutamate and l-aminobutyric acid
(GABA) can be measured via microdialysis techniques [37]. TFUS
has also been combined withmeasurements of the forelimb and
hindlimb responses to epidural cortical stimulation (ECS) to
assess the cortical excitability changes after sonication [45].
Alternatively, electroencephalography (EEG) [29], functional
MRI [22,46], PET [32], measurements of peripheral muscle
evoked potentials (MEP) [47], sensory evoked potentials (SEP)
[48], somatosensory evoked potentials (SSEP) [21], visual
evoked potentials (VEP) [49] or auditory evoked potentials (AEP)
[39] give non-invasive but less speciﬁc measurements of neural
activity changes.
 Undesired changes in animal behavior: TFUS may affect normal
behavior in unintended ways. In animals, this is controlled by
monitoring of every day behavior, like food uptake, defecation
and movement behavior and checking for signals of pain and
distress or change in weight [28e30,32e34,45,50]. In addition,
tasks such as the rotorod task and wire-hanging task allow for
quantitatively assessing the impact of TFUS on speciﬁc aspects
of behavior [27]. One study induced ischemic stroke in mice and
compared the behavioral changes of the mice which weretreated with TFUS via a balance test and an adhesive removal
test [19].
Adverse effects can be caused by cavitation or tissue heating. As
outlined above, cavitation is prevented by controlling the pressure
levels. While the temperature increase in the brain can be roughly
estimated using Equations (7) and (8) in the SupplemetaryMaterial
[17,19,27,30,34,35,48,51], some studies inserted a thermocouple
[27,28,33,45,48] or an optical ﬁber based thermal sensor [36] in the
brain of the animal after craniotomy to track the temperature
change in real time during sonication. A non-invasive alternative to
this approach is measuring the temperature increase with ther-
mocouples in a phantom [33], or MR thermometry [21,29,39,52],
which exploits temperature sensitive MR parameters such as the
water proton resonance frequency, or T1 and T2 relaxation times
[53].
So far, most TFUS studies used animal models. Tests for adverse
effects in the few human studies were based on neurological ex-
aminations and/or structural MR imaging before and at one or
several time points after the experiment [17,51,54]. In some of the
studies, the participants were additionally contacted by telephone
2 months after the experiment and interviewed about any changes
in their mental and physical health status, including experiences of
any discomfort [17,51]. A pre-print manuscript [55] presents results
of phone interviews based on a ‘Participant report of symptoms
questionnaire’ of 64 participants who had participated in one or
more of seven human TFUS experiments before.
Results
Studies screened in this review
This systematic review follows PRISMA guidelines [9,10], and
the PRISMA checklist can be found in the Supplementary Methods
(Table S1). The reviewing process shown in the PRISMA diagram
Flow (Fig. 1) resulted in the selection of 31 peer-reviewed and 2
pre-published studies included in this review. From each of those
papers (a complete list with citations is shown in Table 2), the
sonication parameters (Table 2) and the methods used to assess
safety and adverse effects (Table 3) were extracted and categorized
as described further below. Often, only some of the safety indices
were reported. In that case, we give estimated values when
possible. The risk of bias was assessed and is reported in a separate
section in the Supplementary Material.
BBB opening
BBB opening did not occur in any of the included studies
[28e30], except for two cases where it was intentionally provoked
in control conditions [27,31], using a high Isppa of 280W/cm2 [31] or
an ultrasound contrast agent [27].
Bleeding
Several studies [2,19,22,28,32,33,36e38] tested for bleeding,
without ﬁnding evidence for it. A further study [34] tested different
sonication parameters on eight sheep in total, and reported four
animals with micro-hemorrhages in the primary visual cortex after
undergoing 600 sonications at 6.6W/cm2 Isppa (6 repetitions of 100
sonications, with 30 s gaps). While the reported value for Isppa is
within FDA limits, our calculated value for Ispta of 3.3W/cm2 is
exceeding the diagnostic limit, and is also slightly higher than the
limit for physiotherapeutic US of 3W/cm2. Interestingly, a sheep
undergoing a single sonication at an Isppa of 13.4W/cm2 did not
present micro-hemorrhages. In another study [35], 1 of 37 rats was
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time (<9 s using 1ms TBD, 50% duty cycle and 300ms SD). It
exhibited several areas containing hemosiderin, which indicate the
potential of local bleeding, while none of the other animals showed
any sign of bleeding.
Cell damage or death
Most of the studies testing for cell damage or death
[2,19,21,22,27e30,32e40] did not observe harmful effects of TFUS.
One recent study [31] observed no differential GFAP expression
between the control and sonicated hemisphere for Isppa¼ 0.69W/
cm2, suggesting the absence of neural trauma. However, an
increased number of astrocytes was observed for a control condi-
tion with Isppa¼ 280W/cm2 (~1.5 times above the FDA limit).
Interestingly, no damage was observed even when AEP was not
fully recovered after one month [39] in rats.
Long-term change of neural activity
Yoo et al. [29] tested parameter ranges for excitatory and
inhibitory TFUS effects in craniotomized rats. While excitatory ef-
fects were very short-termed, suppression effects lasted several
minutes. A reduction in the EEG response of up to 80% and a cor-
responding reduction of the BOLD signal that both lasted up to
10min were reported for a long sonication duration of 9 s. Dalla-
piazza et al. [21] observed peak electrophysiological suppression in
SSEP 5min post-treatment, and the values returned to near base-
line within 20min. A further study [31] tested the facilitatory ef-
fects of ultrasound on somatosensory evoked potentials by
measuring the changes in fractional ﬂuorescence in the brains of
mice dyed with voltage sensitive dyes. The TFUS-related changes
disappeared within 20min after ultrasound stimulation. Yang et al.
[37] observed a decreased extracellular GABA level (approximately
20% below baseline) compared to a control group that lasted up to
100min after the sonication ended. The same effect was not
observed for glutamate. Gulick et al. [45] showed that TFUS
signiﬁcantly suppressed forelimb and hindlimb responses to ECS
for several minutes after the stimulation blocks, even though ef-
fects immediately after single, short TFUS trials were absent. Kim
et al. [32] observed a local increase in glucose metabolism induced
by FUS to rat brain. This effect was demonstrated via PET imaging,
which was started 20min after the sonication and performed for
1 h. After that time, the metabolism had still not returned to
baseline. In a work [22] on primates, the authors observed change
in functional connectivity after a long sonication of 40 s at
Ispta¼ 7W/cm2. The change lasted for more than 1 h after soni-
cation. A similar effect was observed in a related work [46], where
they used a sonication of 40 s at amaximum Ispta of 15.3W/cm2. Yoo
et al. [48] observed that the SEP signals after 10min sonication
were distinctively different compared to the control condition,
even 35min after the sonication. Daniels et al. [39] observed a full
recovery of AEP amplitudes in rats within maximum 1 week post-
treatment with Isppa¼ 2.3W/cm2, while the signal from 5 out of 10
rats recovered up to onemonth post-treatment for an Isppa¼ 4.6W/
cm2. In the same study, 1 out of 5 pigs showed a fully recovered
signal 1 h post-treatment while the other did not show any re-
covery 3 h post-treatment (in all 5 cases, Isppa¼ 4.6W/cm2). Kim
et al. [49] observed an increase in VEP in rats up to 5min post-
treatment with Isppa¼ 5W/cm2 and a slight increase of VEP 150 s
after treatment when Isppa¼ 3W/cm2. One study [19] induced
ischemic stroke in mice and found a better sensorimotor perfor-
mance in mice that underwent 20min TFUS session via a balance
test and an adhesive removal test. These improvements lasted for 4
weeks after treatment, suggesting an enhancement in brainplasticity. In the same study, the TFUS treatment in cerebellar LCN
signiﬁcantly lowered the percentage change in increased water
content and tissue swelling in the ipsilateral hemisphere to the
stroke.
Animal behavior
Several studies tested for changes from normal daily behavior
after the sonication studies [28e30,32e34,45,50], but did not ﬁnd
any abnormalities. A single study also employed behavioral tasks
[29] (rotorod running task and wire-hanging task), without
revealing differences in motor performance.
Temperature
Theoretical calculations based on Equations (7) and (8) in the
Supplementary Methods suggest that “typical” TFUS parameters
used so far in most studies cause negligible temperature increases
in brain tissue [17,19,27,30,34,35,48,51]. In a recent study [22], this
was partly conﬁrmed using the more realistic bio-heat equation to
estimate the temperature increase after 40 s of TFUS through a
3mm thick skull, with an Ispta¼ 7W/cm2 in the brain. The maximal
increase in the brain was less than 0.2 C. Interestingly, however,
they found rather strong increases in the skull (2.8 C). Also
experimental results show mostly only small temperature in-
creases due to sonication [27,28,33,36,48]. However, it is important
to note that the overall temperature increase depends on the
combination of several TFUS parameters. For example, one study
[36] reported ameasured peak temperature increase of 0.2 C for an
extended stimulation (~30min) at a low Ispta230mW/cm2 at
1MHz (1.6 C at 5MHz for otherwise same parameters). In contrast,
another study [45] reported a temperature increase up to 3 C after
two blocks of 5min stimulation at 200 kHz, separated by a 2min
break, at Ispta¼ 4.5W/cm2 and a MI¼ 3.1 (higher than the allowed
limit). Both studies applied longer durations than used in most
other TFUS studies so far, but the combination with the higher Ispta
caused noticeable temperature rises in the second study.
A temperature increase of 0.5 C was reported through MR
thermometry after 30 s sonication at Isppa¼ 9.9W/cm2 [52].
Another study [39] reported temperature variation within the
measurement noise level of the baseline temperatures (±2 C) with
MR thermography. The strongest effect was reported by a study
using MR thermometry (sensitivity 0.3± 0.06 C [29]), demon-
strating an increase of ~0.7 C in the sonicated area [29], using an
Isppa¼ 23W/cm2 for 27 s. Dallapiazza et al. [21] showed a negligible
temperature increase during treatment using both MR thermom-
etry and estimations based on the bio-heat equation.
Findings from human studies
In a recent preprint work [47], the authors tested the effects of
ultrasound stimulation on motor cortex excitability measured by
single-pulse transcranial magnetic stimulation (TMS). They report
signiﬁcant changes in the recorded muscle responses to TMS only
when it was applied during, but not after, sonication. Follow-up
neurological exams and anatomical MRIs after the TFUS experi-
ment did not reveal any abnormalities or changes in the mental or
physical status, nor any discomfort associated with the procedure
[17,51,54]. Follow-up interviews at later time points conﬁrmed
those observations. A recent study published as preprint [55] pre-
sents results from a follow-up questionnaire after TFUS that could
be obtained from 64 out of in total 120 participants. Seven subjects
reported mild or moderate symptoms (mild neck pain, scalp
tingling, headache, difﬁculty paying attention, muscle twitches and
anxiety) that they felt were possibly or probably related to the
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The authors found a linear correlation (r¼ 0.797, p¼ 0.0319) be-
tween Isppa and the occurrence of observed symptoms among the 7
subjects who reported mild to moderate symptoms that were
perceived as ‘possibly’ or ‘probably’ related to participation in TFUS
experiments.Discussion and conclusions
Harmful effects of TFUS were absent in the majority of the 33
studies reviewed here. In two cases, microhemorrhages occurred in
a subset of the tested animals when using a high Ispta of 11.2W/cm2
for a short duration [35] or an Ispta of3.3W/cm2 for a high number
of sonications (500) given at a relatively short ISI of 1s [34]. Both
doses are clearly above the safety limits of the FDA guidelines for
diagnostic US and above the IEC standard 60601-2-5 for physio-
therapy US equipment. However, this also holds for several other
included studies, where no adverse effects were reported. While
the parameters chosen in one of the studies [35] did not result in
substantial heating, as also pointed out by the authors, the high Ispta
of 11.2W/cm2 differentiates it from many other TFUS studies. That
might indicate that mechanical effects caused the micro-
hemorrhages, even though the limits for MI and Isppa were not
exceeded. However, as this was observed in only one of the tested
animals, this conclusion remains very speculative and a replication
including sham controls would be favorable to ensure that the
microhemorrhages were indeed related to TFUS. In the second
study [34], the chosen parameter combination might have led to a
high total energy deposit, opening the possibility that a thermal
mechanism underlay the adverse effects that occurred in four an-
imals. For example, Gulick et al. [45] observed a temperature in-
crease of 3 C for a less intense protocol using an Ispta¼ 4.5W/cm2
and in total 180 sonications in a time period of 13min. It seems
reasonable to assume that heating might have been even higher in
the four animals that showed microhemorrhages in Ref. [34] and
indicates that calculating the temperature increase for a single
sonication, as done in Ref. [34], can strongly underestimate the real
increase.
While Isppa stayed below the safety limit in all studies, MI
exceeded the limit in two studies [45,46] and Ispta exceeded the FDA
limits for diagnostic US in soft tissue in 14 out of the 20 studies in
which Ispta was reported or could be calculated post hoc (values
after cranial transmission or for craniotomized animals). Ispta was
also above the physiotherapeutic limit in 11 of the 20 studies. This
suggests that Ispta is the most sensitive safety index in case of TFUS
and, unlike current practice, should be reported so that it can be
followed up by a more detailed estimation of the thermal effects
when its limits are exceeded. We consider this relevant as the
current studies indicate that TFUS parameters within the FDA limits
for diagnostic US might often lack neural stimulation effectiveness.
For example, an Ispta of around 2W/cm2 for pulsed waves and 4W/
cm2 for continuous waveswas necessary to reach a 50% success rate
for stimulation at 500 kHz [7]. Similarly, while many studies
included in this review reported neural effects for parameters
within the safety limits [2,19,27,31,33,48,49,52,56], several studies
found stable effects only when exceeding at least one of the safety
indices ([28e30,34,35] and Table 2). In addition, recent studies
show that heating of the skull (potentially causing indirect heating
of soft tissue) and/or brain tissue can reach several degrees for
more intense and long protocols [22,45]. The systematic assess-
ment of heating will thus be relevant in future studies that might
aim at extending the parameter envelope of TFUS and should be
part of any safety test of new sonication regimes in particular for
human TFUS.It is worth noting that the safety limit of 720mW/cm2 for Ispta,
which was generally used in TFUS studies so far and which we also
applied here, was introduced to limit the heating in soft tissue. In
case of transcranial US, the FDA limits for diagnostic US actually
apply an even stricter limit of 94mW/cm2 for Ispta to prevent
excessive heating of the skull, which absorbs most of the beam
energy. It seems that almost none of the studies published so far
reported neural effects for intensities below this threshold. How-
ever, it is important to stress that both limits are based on worst-
case scenarios and exceeding them does not necessarily mean
that strong heating occurs. Rather, the FDA standard for diagnostic
US requires a case-by-case estimation of the maximum tempera-
ture rise in soft tissue and skull once they are exceeded, speciﬁc for
the used ultrasound parameters and setup. Simulations of the
propagations of the TFUS beam through the skull, combined with
evaluations of the bio-heat equation for TFUS [22], might be valu-
able tools that allow realistic estimates of the amount of heating for
new sonication regimes on a more standard basis.
The neural aftereffects can exceed 1 h [22,32,46], making TFUS a
potent neuromodulation modality. This is encouraging for thera-
peutic applications. In contrast to diagnostic US, future TFUS ap-
plications might resort to repeated sessions over extended time
periods to achieve and maintain therapeutic efﬁcacy. As such, a
safety framework will also need to cover these more intense set-
tings (see, e.g. Refs. [57,58] for a related example of adverse effects
that only occurred after repeated applications in case of trans-
cranial direct current stimulation) or combinations of TFUS with
other brain stimulation techniques. This will require safety studies
that speciﬁcally test this parameter space in order to inform an
international consensus on accepted settings and procedures,
similar to established non-invasive brain stimulation methods [59].
Along similar lines, in the few TFUS studies performed in humans
so far, the type and extent of follow up exams differed strongly
[17,51,54,55]. This suggests a need for guidelines that provide a
secure framework for experimental settings and practical proced-
ures, includingmandatory safety screening and appropriate follow-
up procedures. For example, the importance of establishing best
practices also for apparently simple procedures was highlighted in
a recent review [60] of low-intensity low-frequency US
(20e100 kHz), showing that US can cause skin damage due to in-
ertial effect cavitation in the coupling gel if non-degassed gel is
employed.
Along similar lines, guidelines are important to prevent in-
tensity hotspots that can occur due to unintended standing waves
and focusing effects of the skull. While these effects more likely
emerge in small animals [50], they have been shown to be also
relevant in non-human primates for targets close to the skull base
such as the amygdala [46]. Moreover, a retrospective modeling
study [61] suggests that unwanted secondary hotspots might have
been the cause of intracerebral hemorrhages that occurred in a
clinical trial on transcranial low frequency ultrasound for sono-
thrombolysis [68] and that resulted in the early termination of the
trial. Finally, the reviewed studies differed in regards to the choice
of the stated safety-relevant parameters and the way those were
assessed. A more standardized reporting of the relevant pulse pa-
rameters and of all safety indices of the FDA guidelines is a pre-
requisite for the development of future TFUS guidelines for human
applications. Accurate estimation of the TFUS intensity after cranial
transmission is particularly challenging in humans, as it has to rely
on hydrophone measurements based on “representative” skull
samples or computer simulations [17,51,62]. The uncertainty range
of the intensity estimates obtained by these procedures seems still
unclear [63,64], and contributes to variations in the values reported
across studies. As such, it seems useful that future studies
C. Pasquinelli et al. / Brain Stimulation 12 (2019) 1367e1380 1379additionally state intensity values for a pure water background to
ensure good comparability of the baseline TFUS parameters.
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